Brian Higgins
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Molecular Biology top 2%
- Melanoma and MAPK Pathways
- Protein Kinase Regulation and GTPase Signaling
- Protein Degradation and Inhibitors
Papers in
- Oncology 17
- Cancer-related Molecular Pathways 14
- Colorectal Cancer Treatments and Studies 3
-
- Melanoma and MAPK Pathways 8
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- Kathryn E. Packman (18 shared papers)Kenneth Daniel Kolinsky (16 shared papers)David C. Heimbrook (11 shared papers)Christian Tovar (9 shared papers)Zoran Filipovic (5 shared papers)Lyubomir T. Vassilev (5 shared papers)Xiaolan Zhao (1 shared paper)Binh Thanh Vu (1 shared paper)
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)Investigational New Drugs (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)ACS Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Brian Higgins
35 papers receiving 4.7k citations
Brian Higgins's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.5k
- Molecular Biology 2.1k
- Computational Theory and Mathematics 321
- Cancer Research 252
- Genetics 163
Countries citing papers authored by Brian Higgins
This map shows the geographic impact of Brian Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Higgins more than expected).
Fields of papers citing papers by Brian Higgins
This network shows the impact of papers produced by Brian Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Higgins. The network helps show where Brian Higgins may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Higgins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma Hit paper breakdown → | 2010 | 1516 |
| 2 | 2006 | 585 | |
| 3 | Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development Hit paper breakdown → | 2013 | 498 |
| 4 | 2010 | 348 | |
| 5 | 2020 | 313 | |
| 6 | 2011 | 196 | |
| 7 | 2011 | 150 | |
| 8 | 2004 | 131 | |
| 9 | 2006 | 102 | |
| 10 | 2006 | 95 | |
| 11 | 2017 | 89 | |
| 12 | 2013 | 80 | |
| 13 | 2011 | 67 | |
| 14 | 2014 | 63 | |
| 15 | 2021 | 61 | |
| 16 | 2014 | 59 | |
| 17 | 2012 | 52 | |
| 18 | 2014 | 50 | |
| 19 | 2006 | 43 | |
| 20 | 2020 | 43 |
About Brian Higgins
Brian Higgins is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Organic Chemistry, having authored 35 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Melanoma and MAPK Pathways (8 papers), Angiogenesis and VEGF in Cancer (4 papers), Acute Myeloid Leukemia Research (3 papers), Synthesis and biological activity (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (1.5k citations), Molecular Biology (2.1k citations), Computational Theory and Mathematics (321 citations), Cancer Research (252 citations) and Genetics (163 citations). Brian Higgins has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Kathryn E. Packman, Kenneth Daniel Kolinsky, David C. Heimbrook, Christian Tovar, Zoran Filipovic, Lyubomir T. Vassilev, Xiaolan Zhao, Binh Thanh Vu, Weiguo Qing and James Rosinski. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Investigational New Drugs, Cancer Chemotherapy and Pharmacology and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.